We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00240396
Recruitment Status : Withdrawn (We were not able to enroll patients.)
First Posted : October 18, 2005
Last Update Posted : March 22, 2017
Information provided by (Responsible Party):
Lars Richardson, Beth Israel Deaconess Medical Center

Brief Summary:
The purpose of this prospective randomized study is to evaluate the risks and benefits of using bimodal analgesia, (i.e. Narcotics and NSAIDS) vs Narcotics alone post long bone fracture.

Condition or disease Intervention/treatment Phase
Tibia Fracture Femur Fracture Humerus Fracture Drug: Narcotics alone Drug: Narcotics and NSAIDS Not Applicable

Detailed Description:

This will be a prospective, randomized, control trial looking at the benefit of bimodal analgesia in the treatment of long bone fractures. The traditional pain control regimen following fracture fixation typically involves a course of narcotics on an as-needed basis for pain relief. Recent data has shown that adding NSAIDS to the pain regimen as part of a bimodal approach to pain control, improves the efficacy of pain management and reduces narcotic use. Laboratory research on NSAIDs as it pertains to bone healing, however, has shown in animal models that there may be a positive association between NSAIDS and non-union rates. In other words, NSAIDS may prevent or delay bone healing. These results, however, have not been tested prospectively in humans.

The purpose of this study is to look at the combination of NSAIDS and narcotics post long bone fracture and monitor the effects on narcotic use and healing rates to ultimately and conclusively establish the risk or benefit of NSAIDS after long bone fracture.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture
Study Start Date : October 2005
Actual Primary Completion Date : September 24, 2007
Actual Study Completion Date : September 24, 2007

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. pain score
  2. Amount of narcotics used
  3. time to fracture healing

Secondary Outcome Measures :
  1. return to activity
  2. complications
  3. reoperation rate

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • skeletally mature patients over the age of 18 years
  • Fracture of Tibia, femur, or Humerus.

Exclusion Criteria:

  • Open fractures grade III
  • Open fractures with suspected compartment syndrome
  • history of prior fracture in particular limb.
  • Concurrent usage of Steroid drugs, and immunosuppressants.
  • Prior or current history of GI bleeding.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00240396

Layout table for location information
United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Layout table for investigator information
Principal Investigator: Lars C Richardson, MD Beth Israel Deaconess Medical Center
Layout table for additonal information
Responsible Party: Lars Richardson, Instructor in Orthopedic Surgery, Part-time, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT00240396    
Other Study ID Numbers: 2005P000205
First Posted: October 18, 2005    Key Record Dates
Last Update Posted: March 22, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Lars Richardson, Beth Israel Deaconess Medical Center:
Additional relevant MeSH terms:
Layout table for MeSH terms
Fractures, Bone
Femoral Fractures
Humeral Fractures
Tibial Fractures
Wounds and Injuries
Leg Injuries
Arm Injuries
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents